Gary Emmanuel
Subscribe to Gary Emmanuel's Posts
Gary Emmanuel focuses his practice on corporate securities matters. With over 15 years of experience, Gary represents both domestic and foreign companies that are navigating the process of capital raising, including initial public offerings, registered direct offerings, follow-on offerings, private placements, private investment in public equities (PIPEs) and bridge financings. Gary has worked extensively with biotechnology and other life science companies, both as company counsel and as underwriter's counsel. Read Gary Emmanuel's full bio.
Transformative Healthcare Collaboration Opportunities Emerge from COVID-19 Pandemic
By Stephen Bernstein, Gary Emmanuel, Jennifer S. Geetter, Lisa Schmitz Mazur, Vernessa T. Pollard, Michael Ryan, Joshua Spielman and Kristian Werling on Feb 17, 2021
Posted In Employee Benefits, Health and Welfare Plans, Privacy and Data Security
The seismic, virtually overnight transformation of healthcare delivery as a result of the pandemic has flung open doors to innovation, as a diverse cross-section of digital health and life sciences stakeholders mobilize crisis resources; adjust operations for enhanced screening, sanitization and social distancing measures; harness telehealth capabilities to deliver healthcare remotely; and identify opportunities for...
Continue Reading
ISS and Glass Lewis Update Proxy Voting Guidelines for 2019
By Heidi J. Steele, Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Andrew Liazos, Eric Orsic, Gary Emmanuel and Hank Goldberg on Jan 3, 2019
Posted In Executive Compensation
Institutional Shareholder Services Inc. and Glass, Lewis & Co., LLC both recently issued their annual proxy voting guideline updates. As revised, these guidelines have important implications for companies preparing for the 2019 proxy season. Access the full article.
Continue Reading
Capital Markets & Public Companies Quarterly: Expanding Relief under Smaller Reporting Company, Reg A+ and Rule 701, SEC Enforcement of Cybersecurity Disclosures and Other News
By Robert H. Cohen, Thomas P. Conaghan, Thomas J. Murphy, William Hadler, Eric Orsic, Gary Emmanuel, Heidi J. Steele and Mark J. Mihanovic on Aug 2, 2018
Posted In Executive Compensation
During the previous quarter, the SEC acted to expand the number of companies that may rely on the “smaller reporting company” scaled disclosure regime and Congress directed revisions to the Regulation A+ and Rule 701 exemptions. The SEC also took enforcement action on a major cybersecurity breach, reinforcing its recent interpretive guidance on the subject....
Continue Reading
Capital Markets & Public Companies Quarterly: 2018 Proxy Season Pointers, Disclosing the “Tax Cuts and Jobs Act,” Shareholder Proposals and ICOs
By Eric Orsic, Gary Emmanuel, Heidi J. Steele, Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Thomas J. Murphy and William Hadler on Jan 25, 2018
Posted In Executive Compensation
The end of a year and beginning of the next generally starts the countdown to the public company proxy season. But before moving into 2018, registrants would be well served by first looking back to the guidance that came out of the SEC at the end of 2017. During the last quarter, the SEC staff...
Continue Reading
SEC Publishes Helpful Guidance on Pay Ratio Disclosure
By Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Thomas J. Murphy, Andrew Liazos, Eric Orsic, Gary Emmanuel and Heidi J. Steele on Oct 26, 2017
Posted In Benefit Controversies, Executive Compensation
The SEC recently confirmed that the new CEO pay ratio disclosure rules mandated in the Dodd-Frank Act will go into effect in the 2018 proxy season. To assist companies in preparation of the new disclosure, the SEC published interpretive guidance on September 21, 2017. Continue reading.
Continue Reading
